Cargando…

Effects of the factor Xa inhibitor rivaroxaban on the differentiation of endothelial progenitor cells

BACKGROUND: We evaluated the efficacy of the factor Xa inhibitor rivaroxaban on the differentiation ability of vascular endothelial progenitor cells (EPCs), which play roles in vascular injury repair and atherogenesis. Antithrombotic treatment in patients with atrial fibrillation undergoing percutan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sohma, Ryoichi, Sakuma, Masashi, Obi, Syotaro, Nishino, Setsu, Inoue, Ken-ichi, Kishimoto, Satoko, Lu, Tianyang, Toyoda, Shigeru, Inoue, Teruo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236699/ https://www.ncbi.nlm.nih.gov/pubmed/37268884 http://dx.doi.org/10.1186/s12872-023-03318-4

Ejemplares similares

Mobilization of progenitor cells and assessment of vessel healing after second generation drug-eluting stenting by optical coherence tomography
por: Sakuma, Masashi, et al.
Publicado: (2018)

Mobilization of progenitor cells and vessel healing after implantation of SYNERGY in acute coronary syndrome
por: Sakuma, Masashi, et al.
Publicado: (2021)

Surgical Injury and Ischemia Prime the Adipose Stromal Vascular Fraction and Increase Angiogenic Capacity in a Mouse Limb Ischemia Model
por: Kishimoto, Satoko, et al.
Publicado: (2020)

Cancer‐associated fibroblasts show heterogeneous gene expression and induce vascular endothelial growth factor A (VEGFA) in response to environmental stimuli
por: Inoue, Ken‐ichi, et al.
Publicado: (2019)

Heat induces myogenic transcription factors of myoblast cells via transient receptor potential vanilloid 1 (Trpv1)
por: Obi, Syotaro, et al.
Publicado: (2018)

Short-term Safety and Mid-term Efficacy of Prasugrel Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention
por: Koyabu, Yota, et al.
Publicado: (2019)

Time-restricted feeding prevents high-fat and high-cholesterol diet-induced obesity but fails to ameliorate atherosclerosis in apolipoprotein E-knockout mice
por: Inoue, Ken-ichi, et al.
Publicado: (2020)

Prediction of Acute-phase Complications in Patients with Infectious Endocarditis
por: Saito, Fumiya, et al.
Publicado: (2019)

Pacemaker Treatment for Apical Hypertrophic Cardiomyopathy in the Setting of an Apical Ventricular Aneurysm
por: Toyoda, Shigeru, et al.
Publicado: (2021)

Serum adiponectin and TNFα concentrations are closely associated with epicardial adipose tissue fatty acid profiles in patients undergoing cardiovascular surgery
por: Sawaguchi, Tatsuya, et al.
Publicado: (2017)

Dextran induces differentiation of circulating endothelial progenitor cells
por: Obi, Syotaro, et al.
Publicado: (2014)

Clinical Usefulness of New R-R Interval Analysis Using the Wearable Heart Rate Sensor WHS-1 to Identify Obstructive Sleep Apnea: OSA and RRI Analysis Using a Wearable Heartbeat Sensor
por: Arikawa, Takuo, et al.
Publicado: (2020)

Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients
por: Nakajima, Toshiaki, et al.
Publicado: (2019)

Association of serum leptin and adiponectin concentrations with echocardiographic parameters and pathophysiological states in patients with cardiovascular disease receiving cardiovascular surgery
por: Sawaguchi, Tatsuya, et al.
Publicado: (2019)

Relationship between the serum GDF-15 concentration and muscle function in female patients receiving aortic valve replacement (TAVR, SAVR): Comparison with healthy elderly female subjects
por: Fukuda, Taira, et al.
Publicado: (2022)

Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study
por: Masuyama, Taiki, et al.
Publicado: (2020)

Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa–PAR2-Mediated Autophagy Suppression
por: Ito, Yusuke, et al.
Publicado: (2021)

Anti-factor Xa Monitoring and Activated Charcoal for a Pediatric Patient With Rivaroxaban Overdose
por: Carr, Brendan M., et al.
Publicado: (2018)

Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability
por: Harenberg, Job, et al.
Publicado: (2011)

Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation
por: Horinaka, Shigeo, et al.
Publicado: (2017)

DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban)
por: Ryu, Rachel
Publicado: (2022)

The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term
por: Nasuno, Takahisa, et al.
Publicado: (2015)

Authors' Reply: How to Construct Novel Criteria for Predicting Complication with Infectious Endocarditis
por: Toyoda, Shigeru, et al.
Publicado: (2019)

Association of serum concentrations of irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients
por: Kaneda, Hiroyuki, et al.
Publicado: (2018)

Rivaroxaban – an oral, direct Factor Xa inhibitor – lessons from a broad clinical study programme
por: Haas, Sylvia
Publicado: (2009)

Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice
por: Wu, Tao-Cheng, et al.
Publicado: (2015)

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system
por: Jakowenko, Nicholas, et al.
Publicado: (2020)

Rivaroxaban‐calibrated chromogenic anti‐Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation
por: Lucas, Fabienne, et al.
Publicado: (2021)

Association between serum GDF-15, myostatin, and sarcopenia in cardiovascular surgery patients
por: Nishikawa, Riichi, et al.
Publicado: (2022)

The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty
por: Wang, Han, et al.
Publicado: (2023)

Muscle Thickness of Anterior Mid-Thigh in Hospitalized Patients: Comparison of Supine and Standing Postures
por: Yasuda, Tomohiro, et al.
Publicado: (2020)

Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial
por: Sakuma, Masashi, et al.
Publicado: (2022)

The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin
por: Solayar, Gandhi N, et al.
Publicado: (2011)

Clinical implication of monitoring rivaroxaban and apixaban by using anti-factor Xa assay in patients with non-valvular atrial fibrillation
por: Ikeda, Kozue, et al.
Publicado: (2016)

Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo
por: Perzborn, E, et al.
Publicado: (2014)

A universal anti‐Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation
por: Willekens, Guido, et al.
Publicado: (2021)

Association of serum growth differentiation factor-15 with eGFR and hemoglobin in healthy older females
por: Yazawa, Hiroko, et al.
Publicado: (2020)

Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease‐Activated Receptor Pathway
por: Ichikawa, Hiroaki, et al.
Publicado: (2019)

Rivaroxaban concentrations in acute stroke patients with different dosage forms
por: Wada, Shinichi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5pmjk0s6nqjo41due7ajs5r8d1